Search Results - "Rosado‐Santander, Nelson R."

Randomized elimination and prolongation of ACE inhibitors and ARBs in coronavirus 2019 (REPLACE COVID) Trial Protocol by Cohen, Jordana B., Hanff, Thomas C., Corrales‐Medina, Vicente, William, Preethi, Renna, Nicolas, Rosado‐Santander, Nelson R., Rodriguez‐Mori, Juan E., Spaak, Jonas, Andrade‐Villanueva, Jaime, Chang, Tara I., Barbagelata, Alejandro, Alfonso, Carlos E., Bernales‐Salas, Eduardo, Coacalla, Johanna, Castro‐Callirgos, Carlos Augusto, Tupayachi‐Venero, Karen E., Medina, Carola, Valdivia, Renzo, Villavicencio, Mirko, Vasquez, Charles R., Harhay, Michael O., Chittams, Jesse, Sharkoski, Tiffany, Byrd, James Brian, Edmonston, Daniel L., Sweitzer, Nancy, Chirinos, Julio A.

“…Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the virus responsible for coronavirus disease 2019 (COVID‐19), is associated with high incidence…”
Get full text

Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial by Cohen, Jordana B, Hanff, Thomas C, William, Preethi, Sweitzer, Nancy, Rosado-Santander, Nelson R, Medina, Carola, Rodriguez-Mori, Juan E, Renna, Nicolás, Chang, Tara I, Corrales-Medina, Vicente, Andrade-Villanueva, Jaime F, Barbagelata, Alejandro, Cristodulo-Cortez, Roberto, Díaz-Cucho, Omar A, Spaak, Jonas, Alfonso, Carlos E, Valdivia-Vega, Renzo, Villavicencio-Carranza, Mirko, Ayala-García, Ricardo J, Castro-Callirgos, Carlos A, González-Hernández, Luz A, Bernales-Salas, Eduardo F, Coacalla-Guerra, Johanna C, Salinas-Herrera, Cynthia D, Nicolosi, Liliana, Basconcel, Mauro, Byrd, James B, Sharkoski, Tiffany, Bendezú-Huasasquiche, Luis E, Chittams, Jesse, Edmonston, Daniel L, Vasquez, Charles R, Chirinos, Julio A

“…Biological considerations suggest that renin–angiotensin system inhibitors might influence the severity of COVID-19. We aimed to evaluate whether continuing…”
Get full text

A randomized clinical trial of lipid metabolism modulation with fenofibrate for acute coronavirus disease 2019 by Chirinos, Julio A., Lopez-Jaramillo, Patricio, Giamarellos-Bourboulis, Evangelos J., Dávila-del-Carpio, Gonzalo H., Bizri, Abdul Rahman, Andrade-Villanueva, Jaime F., Salman, Oday, Cure-Cure, Carlos, Rosado-Santander, Nelson R., Cornejo Giraldo, Mario P., González-Hernández, Luz A., Moghnieh, Rima, Angeliki, Rapti, Cruz Saldarriaga, María E., Pariona, Marcos, Medina, Carola, Dimitroulis, Ioannis, Vlachopoulos, Charalambos, Gutierrez, Corina, Rodriguez-Mori, Juan E., Gomez-Laiton, Edgar, Cotrina Pereyra, Rosa, Ravelo Hernández, Jorge Luis, Arbañil, Hugo, Accini-Mendoza, José, Pérez-Mayorga, Maritza, Milionis, Charalampos, Poulakou, Garyfallia, Sánchez, Gregorio, Valdivia-Vega, Renzo, Villavicencio-Carranza, Mirko, Ayala-García, Ricardo J., Castro-Callirgos, Carlos A., Alfaro Carrasco, Rosa M., Garrido Lecca Danos, Willy, Sharkoski, Tiffany, Greene, Katherine, Pourmussa, Bianca, Greczylo, Candy, Ortega-Legaspi, Juan, Jacoby, Douglas, Chittams, Jesse, Katsaounou, Paraskevi, Alexiou, Zoi, Sympardi, Styliani, Sweitzer, Nancy K., Putt, Mary, Cohen, Jordana B.

“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cytotoxicity may involve inhibition of peroxisome proliferator-activated receptor alpha…”
Get full text